ArticleMedicine2026
TikTok, YouTube, and Bilibili as sources of information on uterine fibroids: A content and quality analysis.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Health-Related Quality of Life in Women with Uterine Fibroids Recruited from Clinical and Online Settings: A Cross-Sectional Comparative Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine fibroids, the most common monoclonal benign tumors of the uterine smooth muscle, show an increasing incidence with age. Currently, social media platforms such as TikTok, YouTube, and Bilibili are increasingly becoming important channels for disseminating health information. However, the quality and reliability of content related to uterine fibroids on these platforms are often unsatisfactory. This study aims to systematically evaluate the quality and content characteristics of uterine fibroid-related videos on 3 major short-video platforms - TikTok, YouTube, and Bilibili - using validated assessment tools. A total of 300 videos (100 per platform) uploaded between 2020 and 2025 were included. Video quality was assessed using the The Journal of the American Medical Association benchmark criteria, modified DISCERN instrument, and Global Quality Score. Content features, uploader identity, presentation format, and engagement metrics were also analyzed. Statistical analyses included nonparametric tests and Spearman correlation. Bilibili consistently outperformed TikTok and YouTube in all quality metrics (The Journal of the American Medical Association, DISCERN, Global Quality Score), though overall video quality across platforms was moderate. Video duration was positively correlated with quality scores (ρ ≈ 0.33 for DISCERN). No significant associations were found between engagement metrics (likes/comments) and professional quality ratings. Key content features such as animated demonstrations, source attribution, and inclusion of recent research advances were significantly associated with higher quality. Overall, content across all platforms exhibits deficiencies. However, videos related to uterine fibroids on Bilibili demonstrate relatively fewer shortcomings, while notable quality disparities persist among the different platforms. Content creators should prioritize videos of 2 to 10 minutes with evidence-based features to improve reliability. Viewers are advised to focus on content depth and source credibility rather than superficial engagement metrics. Enhanced platform regulation and public awareness are urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.